Hepatic tumors in childhood: Experience on 245 tumors and review of literature;Les tumeurs hepatiques de l'enfant: Expérience à propos de 245 tumeurs et revue de la littérature

Annales de Pathologie

Volumn 24, Issue 6, 2004, Pages 536-555

  Fabre, Monique ^a   Yilmaz, Funda ^a   Buendia, Marie Annick ^b  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Child; Cholangiocarcinoma; Choriocarcinoma; FNA; GIST; Glutamine synthetase; Hepatic tumors; Hepatoblastoma; Hepatocellular carcinoma; Histiocytosis; Immunohistochemistry; Incidence; Molecular biology; Rhabdoid tumor; SIOPEL; catenin

Indexed keywords

TUMOR MARKER;

ADENOMATOSIS; ADOLESCENT; BENIGN TUMOR; CANCER INCIDENCE; CARNEY COMPLEX; CHILDHOOD CANCER; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FAMILIAL DISEASE; GASTROINTESTINAL STROMAL TUMOR; GENE ACTIVATION; HAMARTOMA; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER ADENOMA; LIVER CARCINOMA; LIVER FIBROSIS; LIVER METASTASIS; LIVER NODULE; LIVER SARCOMA; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; NODULAR HYPERPLASIA; ONCOGENE; PRESCHOOL CHILD; PROGNOSIS; REVIEW; SCHOOL CHILD; CHILD; CLASSIFICATION; LIVER; METASTASIS; PATHOLOGY;

CHILD; HEPATOBLASTOMA; HUMANS; LIVER; LIVER NEOPLASMS;

EID: 14244254732     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(04)94017-5     Document Type: Review

References (48)

1. Fabre M, Bouvier R. Tumeurs du foie de l'enfant. In: Groupe METAVIR, Pathologie tumorale du foie. Elsevier, Paris, 2002.
2. Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist 2000; 5: 445-53.
3. Tanimura M, Matsui I, Abe J, Ikeda H, Kobayashi N, Ohira M et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res 1998; 58: 3032-5.
4. Parada LA, Limon J, Iliszko M, Czauderna P, Gisselsson D, Hoglund M et al. Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study. Med Pediatr Oncol 2000; 34: 165-70.
5. Schneider NR, Cooley LD, Finegold MJ, Douglass EC, Tomlinson GE. The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4) (q12;q34). Genes Chromosomes Cancer 1997; 19: 291-4.
6. Surace C, Leszl A, Perilongo G, Rocchi M, Basso G, Sainati L. Fluorescent in situ hybridization (FISH) reveals frequent and recurrent numerical and structural abnormalities in hepatoblastoma with no informative karyotype. Med Pediatr Oncol 2002; 39: 536-9.
7. Stocker JT. Hepatoblastoma. Semin Diagn Pathol 1994; 11: 136-43.
8. Rugge M, Sonego F, Pollice L, Perilongo G, Guido M, Basso G et al. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. Liver 1998; 18: 128-33.
9. Fasano M, Theise ND, Nalesnik M, Goswami S, Garcia de Davila MT, Finegold MJ et al. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen. Mod Pathol 1998; 11: 934-8.
10. Saxena R, Leake JL, Shafford EA, Davenport M, Mowat AP, Pritchard J et al. Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg Pathol 1993; 17: 1266-71.
11. Ruck P, Xiao JC. Stem-like cells in hepatoblastoma. Med Pediatr Oncol 2002; 39: 504-7.
12. Zimmermann A. Pediatric liver tumors and hepatic ontogenesis: common and distinctive pathways. Med Pediatr Oncol 2002; 39: 492-503.
13. Prokurat A, Kluge P, Kosciesza A, Perek D, Kappeler A, Zimmermann A. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 2002; 39: 510-8.
14. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 94: 1111-20.
15. Schnater JM, Kohler SE, Lamers WH, von Schweinitz D, Aronson DC. Where do we stand with hepatoblastoma? A review. Cancer 2003; 98: 668-78.
16. Haas JE, Feusner JH, Finegold MJ. Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 2001; 92: 3130-4.
17. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 1999; 59: 269-73.
18. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2000; 19: 498-504.
19. Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogens 2002; 21: 8293-8301.
20. Ovejero C, Cavard C, Périanin A, Hakvoort T, Vermeulen J, Godard C et al. Identification of the leukocyte cell-derived chemotaxin2 (LECT2) as a direct target gene of β-catenin in the liver. Hepatology 2004;40:167-76.
21. Perilongo G, Shafford E, Plaschkes J. Liver Tumour Study Group of the International Society of Paediatric Oncology. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 2000; 1: 94-100.
22. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P et al. International Society of Paediatric Oncology (SIOP) study SIOPEL I. Eur J Cancer 2000; 36: 1418-25.
23. Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P et al. International Society of Paediatric Oncology-SIOPEL 2. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer 2004; 40: 411-21.
24. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R et al. International Society of Pediatric Oncology (SIOP). Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42: 74-83.
25. Czauderna P, Mackinlay G, Perilongo G, Brown J, Shafford E, Aronson D et al. Liver Tumors Study Group of the International Society of Pediatric Oncology. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002; 20: 2798-804.
26. Gruner BA, DeNapoli TS, Andrews W, Tomlinson G, Bowman L, Weitman SD. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol 1998; 20: 274-8.
27. Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003; 97: 2006-12.
28. Sowery RD, Jensen C, Morrison KB, Horsman DE, Sorensen PH, Webber EM. Comparative genomic hybridization detects multiple chromosomal amplifications and deletions in undifferentiated embryonal sarcoma of the liver. Cancer Genet Cytogenet 2001; 126: 128-33.
29. Visser M, Sijmons C, Bras J, Arceci RJ, Godfried M, Valentijn LJ et al. Allelotype of pediatric rhabdomyosarcoma. Oncogene 1997; 15: 1309-14.
30. Gururangan S, Bowman LC, Parham DM, Wilimas JA, Rao B, Pratt CB et al. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer 1993; 71: 2653-9.
31. Simons J, Teshima I, Zielenska M, Edwards V, Taylor G, Squire J et al. Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: a case report. Am J Surg Pathol 1999; 23: 982-8.
32. Cross SS, Variend S. Combined hepatoblastoma and yolk sac tumor of the liver. Cancer 1992; 15: 1323-6.
33. Pickhardt PJ, Fisher AJ, Balfe DM, Dehner LP, Huettner PC. Desmoplastic small round cell tumor of the abdomen: radiologic-histopathologic correlation. Radiology 1999; 210: 633-8.
34. Li P, Wei J, West AB, Perle M, Greco MA, Yang GC. Epithelioid gastrointestinal stromal tumor of the stomach with liver metastases in a 12-year-old girl: aspiration cytology and molecular study. Pediatr Dev Pathol 2002; 5: 386-94.
35. Luks FI, Yazbeck S, Brandt ML, Bensoussan AL, Brochu P, Blanchard H et al. Benign liver tumors in children: a 25-year experience. J Pediatr Surg 1991; 26: 1326-30.
36. Bouyn CI, Leclere J, Raimondo G, Le Pointe HD, Couanet D, Valteau-Couanet D et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97: 3107-13.
37. Lack EE, Ornvold K. Focal nodular hyperplasia and hepatic adenoma: a review of eight cases in the pediatric age group. J Surg Oncol 1986; 33: 129-35.
38. Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H et al. Bi-allelic inactivation of TCFI in hepatic adenomas. Nat Genet 2002; 32: 312-5.
39. Reznik Y, Dao T, Coutant R, Chiche L, Jeannot E, Clauin S et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004; 89: 1476-80.
40. Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1 alpha inactivation. Gastroenterology 2003; 125: 1470-5.
41. Boman F, Bossard C, Fabre M, Diab N, Bonnevalle M, Boccon-Gibod L. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg 2004; 14: 63-6.
42. Leal N, Lopez Santamaria M, Gamez M, Murcia J, Lopez Gutierrez JC, Larrauri J et al. The multifocal hepatic hemangioendothelioma. Is always a benign tumor? Cir Pediatr 2004; 17: 8-11.
43. Prokurat A, Kluge P, Chrupek M, Kosciesza A, Rajszys P. Hemangioma of the liver in children: proliferating vascular tumor or congenital vascular malformation? Med Pediatr Oncol 2002; 39: 524-9.
44. Moran CA, Mullick FG, Ishak KG. Nodular regenerative hyperplasia of the liver in children. Am J Surg Pathol 1991; 15: 449-54.
45. Gurgey A, Mescli L, Renda Y, Olcay L, Kocak L, Erdem G. Factor V Q 506 mutation in children with thrombosis. Am J Haematol 1996; 53: 37-9.
46. Barnard J, Marshall S, Neblett W, Gray G, Ghishan F. Noncirrhotic portal fibrosis after Wilm's tumor therapy. Gastroenterology 1986; 90: 1054-6.
47. Roulot D, Degott C, Chazouilleres O, Oberti F, Cales P, Carbonnell N et al. Vascular involvement of the liverin Turner's syndrome. Hepatology 2004; 39: 239-47.
48. Lee SL, DuBois JJ. Hepatic inflammatory pseudotumor: case report, review of the literature, and a proposal for morphologic classification. Pediatr Surg Int 2001; 17: 555-9.